We examined the interrater reliability of the Structured Interview for DSM-IV Personality (SIDP-IV) in an opioid-dependent patient sample at the criterion as well as at the diagnostic level for both categorical and dimensional data. At the criterion level (Cohen’s kappa ranging from 0.76 to 0.93 and intraclass correlation coefficient ranging from 0.67 to 0.97) as well as at the diagnostic level (Cohen’s kappa ranging from 0.66 to 1.00 and intraclass correlation coefficient ranging from 0.88 to 0.99), the reliability was excellent. The results suggest the SIDP-IV to be an adequate instrument for the assessment of personality disorders in opioid-dependent patients.
Katinka F.M. Damen, MA
Novadic, Network for Addiction Services
NL–5491 TB St. Oedenrode (The Netherlands)
Tel. +31 0413 485858, Fax +31 0413 478369, E-Mail K.Damen@psych.kun.nl
Number of Print Pages : 6
Number of Figures : 0, Number of Tables : 4, Number of References : 25
European Addiction Research
Vol. 10, No. 3, Year 2004 (Cover Date: 2004)
Journal Editor: M. Krausz, Hamburg; A. Uchtenhagen, Zürich; C. Haasen, Hamburg
ISSN: 1022–6877 (print), 1421–9891 (Online)
For additional information: http://www.karger.com/ear
Article / Publication Details
Published online: 7/2/2004
Issue release date: 2004
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 4
ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)
For additional information: http://www.karger.com/EAR
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.